Attend the CSWG Summit to enhance your understanding of shock and improve your center's outcomes.

Abiomed is expanding our therapeutic options for advanced heart failure patients with preCARDIA.

Terrific talk on recovery by Jane Wilcox, MD, MSc Northwestern Medicine reviewing at #ISHLT2022 the FIH experience with BTR focused on #HeartRecovery

Best wishes to all! Such a powerful program! #Movement Dr Roxana Mehran - stellar leadership. Wishing all Women As One find and use your #voice; be optimistic; hold hope; avoid complicity🤍👏🏽

kevinmd.com/2023/02/saving…

Removing an Impella using Prostyle… always useful to train people ex vivo first 😊😊😊 #CardioTwitter #cardiogenicshock

Terrific talk #ACC2023 Impact of #ShockTeams on patient outcomes by Shock Team faculty TriStar Health in Nashville. Ann Gage lead a great case discussion recounting the management decisions resulting from collaboration between interventional cardiology, surgery & heart failure

RECOVER IV will randomize 560 STEMI pts with cardiogenic shock to Impella vs control, with FDA approved Exception From Informed Consent. We need sites who acknowledge equipoise to enroll all consecutive pts. If interested please DM me.

Innovative work in cardiogenic shock pathophysiology-RAAS & Ang II deficiency by Thomas Hanff, MD MSCE & team at University of Utah Health & other #VanquishSHOCK consortium sites: Cleveland Clinic Florida, Inova & U of Toronto Thank you #ISHLT2023 & @Abiomed! David Baran Filio Billia Wayne Batchelor, MD

#EuroELSO2023 Great symposium on LV unloading benefits of Impella in ECMO treated patients Benedikt Schrage Recently began an RCT. Still enrolling participating sites.